Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,586.80
(
1.08%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
112.38
(
7.63%
)
Bitcoin
75,775.26
(
-0.75%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ronpopeil post# 227960

Wednesday, 11/08/2023 10:04:50 AM

Wednesday, November 08, 2023 10:04:50 AM

Post# of 257470
DRRX—(-75%)—misses primary endpoint in alcoholic hepatitis:

https://finance.yahoo.com/news/durect-corporation-announces-topline-results-210100751.html

The numerical improvement in the primary endpoint of mortality or transplant at 90 days did not achieve statistical significance for either dose of larsucosterol.

DRRX has a long history of clinical failures.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today